According to OncoCyte 's latest financial reports the company's current EPS (TTM) is -$13.51. In 2022 the company made an earnings per share (EPS) of -$17.47 an increase over its 2021 EPS that were of -$18.68.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$13.93 | -20.22% |
2022 | -$17.47 | -6.48% |
2021 | -$18.68 | 54.35% |
2020 | -$12.10 | 6.98% |
2019 | -$11.31 | 2.38% |
2018 | -$11.05 | -34.38% |
2017 | -$16.84 | 48.84% |
2016 | -$11.31 | -35.18% |
2015 | -$17.45 |